Bisindolylmaleimide IX (Ro 31-8220 Mesylate)

For research use only.

Catalog No.S7207 Synonyms: Bisindolylmaleimide IX Mesylate

18 publications

Bisindolylmaleimide IX (Ro 31-8220 Mesylate) Chemical Structure

CAS No. 138489-18-6

Bisindolylmaleimide IX (Ro 31-8220 Mesylate) is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively, and also shows potent inhibition against MAPKAP-K1b, MSK1, GSK3β and S6K1.

Selleck's Bisindolylmaleimide IX (Ro 31-8220 Mesylate) has been cited by 18 publications

Purity & Quality Control

Choose Selective PKC Inhibitors

Biological Activity

Description Bisindolylmaleimide IX (Ro 31-8220 Mesylate) is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively, and also shows potent inhibition against MAPKAP-K1b, MSK1, GSK3β and S6K1.
PKCα [1]
(Cell-free assay)
PKCβ2 [1]
(Cell-free assay)
PKCβ1 [1]
(Cell-free assay)
PKCε [1]
(Cell-free assay)
PKCγ [1]
(Cell-free assay)
5 nM 14 nM 24 nM 24 nM 27 nM
In vitro

Ro 31-8220 inhibits rat brain PKC activity with IC50 of 23 nM, and does not show any high degree of selectivity between PKC-α, PKC-β, PKC-γ, and PKC-ε. [1] Ro 31-8220 also inhibits MSK1, MAPKAPK1, RSK, GSK3β and S6K1 with a potency similar to that for PKC. In addition, Ro 31-8220 inhibits voltage-dependent Na+ channels. [2] Ro 31-8220 alters cellular protein kinase C localization and potently inhibits growth of A549 and MCF-7 cells with IC50 of 0.78 μM and 0.897 μM, respectively. [3] RO 31-8220 enhances epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. [4] Ro 31-8220 significantly decreases apoE secretion from primary human macrophages by inhibiting vesicular transport of apoE to the plasma membrane without significantly affecting apoE mRNA or apoE protein levels. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Sf9 MXzGeY5kfGmxbjDhd5NigQ>? NH7PNlFKdmirYnn0bY9vKG:oIFjpd{11[WepZXSgbJVu[W5iTWPLNUBmgHC{ZYPz[YQhcW5iU3[5JINmdGy|LDDJR|UxRTBwMEC4{txO NYT5WoNWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC5PVg{PTFpPkGwPVk5OzVzPD;hQi=>
Sf21 NHPyWW9HfW6ldHnvckBie3OjeR?= MmnFTY5pcWKrdHnvckBw\iCKaYOteIFo\2WmIHj1cYFvKEeVS{PiJIV5eHKnc4Pl[EBqdiCVZkKxJINmdGy|LDDJR|UxRTBwMEO4{txO MlfoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB7OUizOVEoRjFyOUm4N|UyRC:jPh?=
HCT116 MmnSRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? Ml:4OFghcHK| NFr5T5pCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{BwfmW{IHX4dJJme3OrbnegVnNMOiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvQDUQvF2= NITpPXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS4PFY3Oid-MkG0PFg3PjJ:L3G+
PC3 MWjDfZRwfG:6aXPpeJkh[XO|YYm= NY[1fVlWPDhiaILz M4LEc2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVEvPzUQvF2= MlfnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2M{SxOFAoRjJ|NEO0NVQxRC:jPh?=
MDA-MB-231 NFXDRpFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MXm0PEBpenN? MnXZRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPRFGtUWIuOjNzIHPlcIx{KG:4ZYKg[ZhxemW|c3nu[{BTW0t{IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OS55N988US=> MlPZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2OEi2OlIoRjJzNEi4OlYzRC:jPh?=
MCF7 M3O2eWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M1jyWFQ5KGi{cx?= MoS3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|IH;2[ZIh\XiycnXzd4lv\yCUU1uyJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MT65Ou69VQ>? MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR6OE[2Nkc,OjF2OEi2OlI9N2F-
MCF7 MojjR5l1d3SxeHnjbZR6KGG|c3H5 MmTmOFghcHK| NWHrO3JbS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTFwOUdOwG0> NX;VfWdZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0N|QyPDBpPkKzOFM1OTRyPD;hQi=>
DE3 MmPHSpVv[3Srb36gZZN{[Xl? NFzrfJRKdmirYnn0bY9vKG:oIHj1cYFvKG[3bHygcIVv\3SqIGPJVnQyKGW6cILld5Nm\CCrbjDESVMh[2WubIOgZpkh\my3b4LpcYV1emmlIHHzd4F6NCCLQ{WwQVI2|ryP NFnDNXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUezOFA2OCd-MUm3N|QxPTB:L3G+
A549 M{Tjd2Z2dmO2aX;uJIF{e2G7 MX;Jcohq[mm2aX;uJI9nKFOLUmSyJIlvKEF3NEmgZ4VtdHNiYYPz[ZN{\WRiYYOgZYJqdGm2eTD0c{BqdmS3Y3WgbJlx\XKjY3X0fYxifGmxbjDv[kB1fWK3bHnuJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrcx?= NUXndlhsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUexOFk5PjBpPkG3NVQ6QDZyPD;hQi=>
A549 NWm3UWNVTnWwY4Tpc44h[XO|YYm= NYHwfllrOTBidV2= NEXYblRKdmirYnn0bY9vKG:oIGPJVnQzKGmwIFG1OFkh[2WubIOgZZN{\XO|ZXSgZZMh[WKrbHn0fUB1dyCrbnT1Z4UhcHmyZYLhZ4V1gWyjdHnvckBw\iC2dXL1cIlvKGG2IEGwJJVOKGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=> M33Md|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MUS5PFYxLz5zN{G0PVg3ODxxYU6=
MCF7 NYXLfYtFTnWwY4Tpc44h[XO|YYm= M4nXZlExKHWP MoHaNVYhcHK| M1rlN2lvcGmkaYTpc44hd2ZiU1nSWFIhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczD0eYJ2dGmwIHj5dIVz[WOndInsZZRqd25iYYSgNVAhfU1iYX\0[ZIhOTZiaILzJIJ6KFenc4Tldo4h[myxdB?= MoXzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjByM{CzOFMoRjJyMEOwN|Q{RC:jPh?=

... Click to View More Cell Line Experimental Data

In vivo In MLP−/− Mice, Ro 31-8220 (6 mg/kg/d, s.c.) results in a significant increase in cardiac contractility. [6]


Kinase Assay:


- Collapse

Assay of PKC Activity :

Assay mixtures contain 0.2 mg/mL peptide-gamma, 10 μM MgCl2, 0.6 mM CaCl2, 10 μM [γ-32P]ATP, 1.25 mg/mL phosphatidylserine and 1.25 ng/mL phorbol 12-myristate 13-acetate in 20 mM Hepes (pH 7.5), 2 mM EDTA, 1 mM dithiothreitol and 0.02% (w/v) Triton X-100. Peptide-γ is a synthetic peptide, GPRPLFCRKGSLRQKW, resembling the PKC-γ pseudosubstrate site, except that a serine residue replaces the pseudosubstrate alanine, converting the peptide from an inhibitor into a substrat. The assays are started by the addition of 2.5 m-units of enzyme, incubated at 30 °C for 10 min and terminated by spotting on to P81 paper, followed by extensive washing in 75 mM orthophosphoric acid. The papers are then washed in ethanol, dried, and incorporated radioactivity is determined by liquidscintillation spectroscopy.
Cell Research:


- Collapse
  • Cell lines: Human A549 lung and MCF-7 breast carcinoma cells
  • Concentrations: 2.5 μM
  • Incubation Time: 24-48 hours
  • Method:

    Human A549 lung and MCF-7 breast carcinoma cells are obtained from the European Collection of Animal Cell Cultures. Cells (passage number 10-30) are cultured in an atmosphere of 5% carbon dioxide, the former in Ham's F-12 medium with penicillin/streptomycin, the latter in minimum essential medium (Eagle's modification) with additional pyruvate (1 mM) and non-essential amino acids. Both media are supplemented with 10% FCS and glutamine (2 mM). Cells are subcultured routinely twice weekly to maintain logarithmic growth. For cell proliferation studies cells are seeded and incubated with 3 ml of medium including agents, which is replenished at intervals of 48 h (A549) or 72 h (MCF-7). Following incubation for 4 days (A549) or 6 days (MCF-7) with drugs, cell number is assessed using a Coulter Counter Model ZM. In order to achieve PKC depletion, cells are incubated for 24 h with bryostatin 1 (1 μM). Under these conditions growth inhibition caused by bryostatin 1 is negligible. Bryostatin is removed by extensive washing of the cells followed by a 2 h recovery period. In previous work using the A549 cell line this washing procedure has been shown to eliminate bryostatin-mediated effects. The cells are then incubated for a further 24 h with staurosporine, RO 31-8220, UCN-01 or H-7. In some experiments cells are incubated with inhibitor for 48 rather than 24 h, in this case bryostation was not removed and left in the incubate. After removal of agents inhibition of DNA synthesis is evaluated by measurement of [3H]Tdr incorporation into cell. Radioactivity is counted using a Packard 1500 Tricarb scintillation counter.

    (Only for Reference)
Animal Research:


- Collapse
  • Animal Models: MLP−/− Mice
  • Dosages: 6 mg/kg/d
  • Administration: s.c.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 100 mg/mL (180.61 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 553.65


CAS No. 138489-18-6
Storage powder
in solvent
Synonyms Bisindolylmaleimide IX Mesylate
Smiles CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N.CS(=O)(=O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

PKC Signaling Pathway Map

Related PKC Products

Tags: buy Bisindolylmaleimide IX (Ro 31-8220 Mesylate) | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) supplier | purchase Bisindolylmaleimide IX (Ro 31-8220 Mesylate) | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) cost | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) manufacturer | order Bisindolylmaleimide IX (Ro 31-8220 Mesylate) | Bisindolylmaleimide IX (Ro 31-8220 Mesylate) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID